Michael Uhlin, based in Stockholm, SE, is currently a Chief Scientific Officer at Devyser, bringing experience from previous roles at Karolinska Institutet, Desumo Biotechnologies is focused on the development and application of single c and Karolinska University Hospital. Michael Uhlin holds a 2020 - 2024 Professor in Clinical Immunology @ Karolinska Institutet. With a robust skill set that includes Cell Biology, Cell Culture, Immunology, Flow Cytometry, Cell and more, Michael Uhlin contributes valuable insights to the industry. Michael Uhlin has 2 emails on RocketReach.